VolitionRx (VNRX) Earnings Date, Estimates & Call Transcripts → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free VNRX Stock Alerts $0.71 +0.02 (+2.92%) (As of 05/31/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest Earnings SummaryLatest Earnings DateMay. 13EstimatedActual EPS (May. 13) -$0.10 Beat By $0.01 Consensus EPS (May. 13) -$0.11 Get VolitionRx Earnings AlertsEnter your email address below to receive the latest news and earnings results for VNRX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVNRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VNRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. VolitionRx Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.50) EPSNext Year EPS Consensus Estimate: ($0.33) EPSVNRX Earnings Date and InformationVolitionRx last released its earnings results on May 13th, 2024. The medical research company reported ($0.10) EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.01. The company had revenue of $0.17 million for the quarter, compared to analysts' expectations of $0.27 million. VolitionRx has generated ($0.56) earnings per share over the last year (($0.56) diluted earnings per share). Earnings for VolitionRx are expected to grow in the coming year, from ($0.50) to ($0.33) per share. Read More VolitionRx Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript5/13/2024Q1 2024($0.11)($0.10)+$0.01($0.10)$0.27 million$0.17 million3/25/2024Q4 2023-($0.11)($0.11)($0.11)$0.50 million$0.24 million11/14/2023Q3 2023($0.12)($0.11)+$0.01($0.11)$0.26 million$0.17 million 8/14/2023Q2 2023($0.13)($0.14)($0.01)($0.14)$0.29 million$0.22 million 5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million Get the Latest News and Ratings for VNRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VolitionRx and its competitors with MarketBeat's FREE daily newsletter. 5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 millionThis military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million 3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 millionThis military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.11)($0.13)($0.02)($0.13)$0.03 million$0.03 million 11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million 8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1($0.1170)($0.12)($0.0030)($0.12)-$0.03 million 5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million3/22/2021Q4 2020($0.10)($0.11)($0.01)($0.11)$1.13 million$0.01 million3/22/2021Q4 2020($0.10)($0.11)($0.01)($0.11)$1.13 million$0.01 million3/22/2021Q4 2020($0.10)($0.11)($0.01)($0.11)$1.13 million$0.01 million3/22/2021Q4 2020($0.10)($0.11)($0.01)($0.11)$1.13 million$0.01 million3/22/2021Q4 2020($0.10)($0.11)($0.01)($0.11)$1.13 million$0.01 million3/22/2021Q4 2020($0.10)($0.11)($0.01)($0.11)$1.13 million$0.01 million3/22/2021Q4 2020($0.10)($0.11)($0.01)($0.11)$1.13 million$0.01 million3/22/2021Q4 2020($0.10)($0.11)($0.01)($0.11)$1.13 million$0.01 million3/22/2021Q4 2020($0.10)($0.11)($0.01)($0.11)$1.13 million$0.01 million3/22/2021Q4 2020($0.10)($0.11)($0.01)($0.11)$1.13 million$0.01 million3/22/2021Q4 2020($0.10)($0.11)($0.01)($0.11)$1.13 million$0.01 million3/22/2021Q4 2020($0.10)($0.11)($0.01)($0.11)$1.13 million$0.01 millionClaim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now3/22/2021Q4 2020($0.10)($0.11)($0.01)($0.11)$1.13 million$0.01 million3/21/2021Q4 2020($0.10)($0.11)($0.01)($0.11)$1.13 million$0.01 million 11/12/2020Q3 2020($0.11)($0.09)+$0.02($0.09)-- 11/12/2020Q3 2020($0.11)($0.09)+$0.02($0.09)--11/12/2020Q3 2020($0.11)($0.09)+$0.02($0.09)--11/12/2020Q3 2020($0.11)($0.09)+$0.02($0.09)--11/12/2020Q3 2020($0.11)($0.09)+$0.02($0.09)--11/12/2020Q3 2020($0.11)($0.09)+$0.02($0.09)--11/12/2020Q3 2020($0.11)($0.09)+$0.02($0.09)--11/12/2020Q3 2020($0.11)($0.09)+$0.02($0.09)--11/12/2020Q3 2020($0.11)($0.09)+$0.02($0.09)--11/12/2020Q3 2020($0.11)($0.09)+$0.02($0.09)--11/12/2020Q3 2020($0.11)($0.09)+$0.02($0.09)--11/12/2020Q3 2020($0.11)($0.09)+$0.02($0.09)--11/12/2020Q3 2020($0.11)($0.09)+$0.02($0.09)--11/12/2020Q3 2020($0.11)($0.09)+$0.02($0.09)--11/12/2020Q3 2020($0.11)($0.09)+$0.02($0.09)--8/13/2020Q2 2020($0.13)($0.12)+$0.01($0.12)-$0.01 million8/13/2020Q2 2020($0.13)($0.12)+$0.01($0.12)-$0.01 million8/13/2020Q2 2020($0.13)($0.12)+$0.01($0.12)-$0.01 million8/13/2020Q2 2020($0.13)($0.12)+$0.01($0.12)-$0.01 million8/13/2020Q2 2020($0.13)($0.12)+$0.01($0.12)-$0.01 million8/13/2020Q2 2020($0.13)($0.12)+$0.01($0.12)-$0.01 million8/13/2020Q2 2020($0.13)($0.12)+$0.01($0.12)-$0.01 million8/13/2020Q2 2020($0.13)($0.12)+$0.01($0.12)-$0.01 million8/13/2020Q2 2020($0.13)($0.12)+$0.01($0.12)-$0.01 million8/13/2020Q2 2020($0.13)($0.12)+$0.01($0.12)-$0.01 million8/13/2020Q2 2020($0.13)($0.12)+$0.01($0.12)-$0.01 million8/13/2020Q2 2020($0.13)($0.12)+$0.01($0.12)-$0.01 million8/13/2020Q2 2020($0.13)($0.12)+$0.01($0.12)-$0.01 million8/13/2020Q2 2020($0.13)($0.12)+$0.01($0.12)-$0.01 million8/13/2020Q2 2020($0.13)($0.12)+$0.01($0.12)-$0.01 million5/7/2020Q1($0.10)($0.14)($0.04)($0.14)-$0.54 million 5/7/2020Q1 2020($0.10)($0.14)($0.04)($0.14)--5/7/2020Q1 2020($0.10)($0.14)($0.04)($0.14)--5/7/2020Q1 2020($0.10)($0.14)($0.04)($0.14)--5/7/2020Q1 2020($0.10)($0.14)($0.04)($0.14)--5/7/2020Q1 2020($0.10)($0.14)($0.04)($0.14)--5/7/2020Q1 2020($0.10)($0.14)($0.04)($0.14)--5/7/2020Q1 2020($0.10)($0.14)($0.04)($0.14)--5/7/2020Q1 2020($0.10)($0.14)($0.04)($0.14)--5/7/2020Q1 2020($0.10)($0.14)($0.04)($0.14)--5/7/2020Q1 2020($0.10)($0.14)($0.04)($0.14)--5/7/2020Q1 2020($0.10)($0.14)($0.04)($0.14)--5/7/2020Q1 2020($0.10)($0.14)($0.04)($0.14)--5/7/2020Q1 2020($0.10)($0.14)($0.04)($0.14)--5/7/2020Q1 2020($0.10)($0.14)($0.04)($0.14)--2/20/2020Q4 2019($0.11)($0.09)+$0.02($0.09)--2/20/2020Q4 2019($0.11)($0.09)+$0.02($0.09)--2/20/2020Q4 2019($0.11)($0.09)+$0.02($0.09)--Kiss of death from Joe Biden (Ad)I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything.2/20/2020Q4 2019($0.11)($0.09)+$0.02($0.09)--2/20/2020Q4 2019($0.11)($0.09)+$0.02($0.09)--2/20/2020Q4 2019($0.11)($0.09)+$0.02($0.09)--2/20/2020Q4 2019($0.11)($0.09)+$0.02($0.09)--2/20/2020Q4 2019($0.11)($0.09)+$0.02($0.09)--2/20/2020Q4 2019($0.11)($0.09)+$0.02($0.09)--2/20/2020Q4 2019($0.11)($0.09)+$0.02($0.09)--2/20/2020Q4 2019($0.11)($0.09)+$0.02($0.09)--2/20/2020Q4 2019($0.11)($0.09)+$0.02($0.09)--2/20/2020Q4 2019($0.11)($0.09)+$0.02($0.09)--2/20/2020Q4 2019($0.11)($0.09)+$0.02($0.09)--2/20/2020Q4 2019($0.11)($0.09)+$0.02($0.09)--11/12/2019Q3 2019($0.11)($0.10)+$0.01($0.10)$0.06 million$0.02 million11/12/2019Q3($0.11)($0.10)+$0.01($0.10)$0.06 million$0.02 million 11/12/2019Q3 2019($0.11)($0.10)+$0.01($0.10)$0.06 million$0.02 million11/12/2019Q3 2019($0.11)($0.10)+$0.01($0.10)$0.06 million$0.02 million11/12/2019Q3 2019($0.11)($0.10)+$0.01($0.10)$0.06 million$0.02 million11/12/2019Q3 2019($0.11)($0.10)+$0.01($0.10)$0.06 million$0.02 million11/12/2019Q3 2019($0.11)($0.10)+$0.01($0.10)$0.06 million$0.02 million11/12/2019Q3 2019($0.11)($0.10)+$0.01($0.10)$0.06 million$0.02 million11/12/2019Q3 2019($0.11)($0.10)+$0.01($0.10)$0.06 million$0.02 million11/12/2019Q3 2019($0.11)($0.10)+$0.01($0.10)$0.06 million$0.02 million11/12/2019Q3 2019($0.11)($0.10)+$0.01($0.10)$0.06 million$0.02 million11/12/2019Q3 2019($0.11)($0.10)+$0.01($0.10)$0.06 million$0.02 million11/12/2019Q3 2019($0.11)($0.10)+$0.01($0.10)$0.06 million$0.02 million11/12/2019Q3 2019($0.11)($0.10)+$0.01($0.10)$0.06 million$0.02 million11/12/2019Q3 2019($0.11)($0.10)+$0.01($0.10)$0.06 million$0.02 million8/12/2019Q2 2019($0.12)($0.11)+$0.01($0.11)--8/12/2019Q2 2019($0.12)($0.11)+$0.01($0.11)--8/12/2019Q2 2019($0.12)($0.11)+$0.01($0.11)--8/12/2019Q2 2019($0.12)($0.11)+$0.01($0.11)--8/12/2019Q2 2019($0.12)($0.11)+$0.01($0.11)--8/12/2019Q2 2019($0.12)($0.11)+$0.01($0.11)--8/12/2019Q2 2019($0.12)($0.11)+$0.01($0.11)--8/12/2019Q2 2019($0.12)($0.11)+$0.01($0.11)--8/12/2019Q2 2019($0.12)($0.11)+$0.01($0.11)--8/12/2019Q2 2019($0.12)($0.11)+$0.01($0.11)--8/12/2019Q2 2019($0.12)($0.11)+$0.01($0.11)--8/12/2019Q2 2019($0.12)($0.11)+$0.01($0.11)--8/12/2019Q2 2019($0.12)($0.11)+$0.01($0.11)--8/12/2019Q2 2019($0.12)($0.11)+$0.01($0.11)-- 8/12/2019Q2 2019($0.12)($0.11)+$0.01($0.11)-- VolitionRx Earnings - Frequently Asked Questions When did VolitionRx announce their last quarterly earnings? VolitionRx (NYSEAMERICAN:VNRX) last announced its quarterly earning data on Monday, May 13, 2024. Learn more on VNRX's earnings history. Did VolitionRx beat their earnings estimates last quarter? In the previous quarter, VolitionRx (NYSEAMERICAN:VNRX) reported ($0.10) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.11) by $0.01. Learn more on analysts' earnings estimate vs. VNRX's actual earnings. How much revenue does VolitionRx generate each year? VolitionRx (NYSEAMERICAN:VNRX) has a recorded annual revenue of $310,000.00. How much profit does VolitionRx generate each year? VolitionRx (NYSEAMERICAN:VNRX) has a recorded net income of -$30.27 million. VNRX has generated -$0.56 earnings per share over the last four quarters. What is VolitionRx's EPS forecast for next year? VolitionRx's earnings are expected to grow from ($0.50) per share to ($0.33) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ATOS Earnings Results FENC Earnings Results ELTP Earnings Results VERU Earnings Results PROF Earnings Results IXHL Earnings Results DRTS Earnings Results TRVI Earnings Results GLSI Earnings Results ZOM Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Hormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China? This page (NYSEAMERICAN:VNRX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
